IceCure regains compliance with Nasdaq
Seeking Alpha ·
IceCure Medical ( ICCM ) said on Thursday it had regained compliance with Nasdaq's $1.00 minimum bid price requirement after receiving notice from the exchange. Nasdaq closed the bid price deficiency matter after the shares traded at or above $1.00 for 10 consecutive business days. IceCure Medical Ltd (ICCM) Q1 2026 Earnings Call Transcript IceCure Medical to boost share price with 1-for-30 reverse split to regain Nasdaq compliance IceCure gets 180-day Nasdaq extension to regain bid price compliance Seeking Alpha’s Quant Rating on IceCure Medical Historical earnings data for IceCure Medical
DYAX Investor Sentiment
Bullish (Long) 50% · Bearish (Short) 50%
555 participants
Related News
- WisdomTree Premium Equity Income Fund declares monthly distribution of $0.3274
- WisdomTree High Income Laddered Municipal Fund declares monthly distribution of $0.0950
- Is SpaceX's $25B debt sale raising bubble concerns on Wall Street?
- Apple raises iPad and MacBook prices as AI pushes up costs
- Core & Main launches $750M senior notes offering
- WisdomTree Core Laddered Municipal Fund declares monthly distribution of $0.0850